Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical Trial

The effect of dietary fibres on intestinal barrier function has not been well studied, especially in the elderly. We aimed to investigate the potential of the dietary fibres oat β-glucan and wheat arabinoxylan to strengthen the intestinal barrier function and counteract acute non-steroid anti-inflam...

Full description

Bibliographic Details
Main Authors: John-Peter Ganda Mall, Frida Fart, Julia A. Sabet, Carl Mårten Lindqvist, Ragnhild Nestestog, Finn Terje Hegge, Åsa V. Keita, Robert J. Brummer, Ida Schoultz
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/12/7/1954
id doaj-e334b1e6520542bc895270f1caddf17b
record_format Article
spelling doaj-e334b1e6520542bc895270f1caddf17b2020-11-25T02:45:34ZengMDPI AGNutrients2072-66432020-06-01121954195410.3390/nu12071954Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical TrialJohn-Peter Ganda Mall0Frida Fart1Julia A. Sabet2Carl Mårten Lindqvist3Ragnhild Nestestog4Finn Terje Hegge5Åsa V. Keita6Robert J. Brummer7Ida Schoultz8School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Södra Grev Rosengatan 32, 703 62 Örebro, SwedenSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Södra Grev Rosengatan 32, 703 62 Örebro, SwedenSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Södra Grev Rosengatan 32, 703 62 Örebro, SwedenSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Södra Grev Rosengatan 32, 703 62 Örebro, SwedenGenetic Analysis AS, Kabelgata 8, 0580 Oslo, NorwayGenetic Analysis AS, Kabelgata 8, 0580 Oslo, NorwayDepartment of Biomedical and Clinical Sciences, Linköping University, 581 85 Linköping, SwedenSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Södra Grev Rosengatan 32, 703 62 Örebro, SwedenSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Södra Grev Rosengatan 32, 703 62 Örebro, SwedenThe effect of dietary fibres on intestinal barrier function has not been well studied, especially in the elderly. We aimed to investigate the potential of the dietary fibres oat β-glucan and wheat arabinoxylan to strengthen the intestinal barrier function and counteract acute non-steroid anti-inflammatory drug (indomethacin)-induced hyperpermeability in the elderly. A general population of elderly subjects (≥65 years, <i>n</i><i> </i>= 49) was randomised to a daily supplementation (12g/day) of oat β-glucan, arabinoxylan or placebo (maltodextrin) for six weeks. The primary outcome was change in acute indomethacin-induced intestinal permeability from baseline, assessed by an in vivo multi-sugar permeability test. Secondary outcomes were changes from baseline in: gut microbiota composition, systemic inflammatory status and self-reported health. Despite a majority of the study population (85%) showing a habitual fibre intake below the recommendation, no significant effects on acute indomethacin-induced intestinal hyperpermeability in vivo or gut microbiota composition were observed after six weeks intervention with either dietary fibre, compared to placebo.<b> </b>https://www.mdpi.com/2072-6643/12/7/1954dietary fibresprebioticsintestinal permeabilityNSAIDsclinical trialelderly
collection DOAJ
language English
format Article
sources DOAJ
author John-Peter Ganda Mall
Frida Fart
Julia A. Sabet
Carl Mårten Lindqvist
Ragnhild Nestestog
Finn Terje Hegge
Åsa V. Keita
Robert J. Brummer
Ida Schoultz
spellingShingle John-Peter Ganda Mall
Frida Fart
Julia A. Sabet
Carl Mårten Lindqvist
Ragnhild Nestestog
Finn Terje Hegge
Åsa V. Keita
Robert J. Brummer
Ida Schoultz
Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical Trial
Nutrients
dietary fibres
prebiotics
intestinal permeability
NSAIDs
clinical trial
elderly
author_facet John-Peter Ganda Mall
Frida Fart
Julia A. Sabet
Carl Mårten Lindqvist
Ragnhild Nestestog
Finn Terje Hegge
Åsa V. Keita
Robert J. Brummer
Ida Schoultz
author_sort John-Peter Ganda Mall
title Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical Trial
title_short Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical Trial
title_full Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical Trial
title_fullStr Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical Trial
title_full_unstemmed Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical Trial
title_sort effects of dietary fibres on acute indomethacin-induced intestinal hyperpermeability in the elderly: a randomised placebo controlled parallel clinical trial
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2020-06-01
description The effect of dietary fibres on intestinal barrier function has not been well studied, especially in the elderly. We aimed to investigate the potential of the dietary fibres oat β-glucan and wheat arabinoxylan to strengthen the intestinal barrier function and counteract acute non-steroid anti-inflammatory drug (indomethacin)-induced hyperpermeability in the elderly. A general population of elderly subjects (≥65 years, <i>n</i><i> </i>= 49) was randomised to a daily supplementation (12g/day) of oat β-glucan, arabinoxylan or placebo (maltodextrin) for six weeks. The primary outcome was change in acute indomethacin-induced intestinal permeability from baseline, assessed by an in vivo multi-sugar permeability test. Secondary outcomes were changes from baseline in: gut microbiota composition, systemic inflammatory status and self-reported health. Despite a majority of the study population (85%) showing a habitual fibre intake below the recommendation, no significant effects on acute indomethacin-induced intestinal hyperpermeability in vivo or gut microbiota composition were observed after six weeks intervention with either dietary fibre, compared to placebo.<b> </b>
topic dietary fibres
prebiotics
intestinal permeability
NSAIDs
clinical trial
elderly
url https://www.mdpi.com/2072-6643/12/7/1954
work_keys_str_mv AT johnpetergandamall effectsofdietaryfibresonacuteindomethacininducedintestinalhyperpermeabilityintheelderlyarandomisedplacebocontrolledparallelclinicaltrial
AT fridafart effectsofdietaryfibresonacuteindomethacininducedintestinalhyperpermeabilityintheelderlyarandomisedplacebocontrolledparallelclinicaltrial
AT juliaasabet effectsofdietaryfibresonacuteindomethacininducedintestinalhyperpermeabilityintheelderlyarandomisedplacebocontrolledparallelclinicaltrial
AT carlmartenlindqvist effectsofdietaryfibresonacuteindomethacininducedintestinalhyperpermeabilityintheelderlyarandomisedplacebocontrolledparallelclinicaltrial
AT ragnhildnestestog effectsofdietaryfibresonacuteindomethacininducedintestinalhyperpermeabilityintheelderlyarandomisedplacebocontrolledparallelclinicaltrial
AT finnterjehegge effectsofdietaryfibresonacuteindomethacininducedintestinalhyperpermeabilityintheelderlyarandomisedplacebocontrolledparallelclinicaltrial
AT asavkeita effectsofdietaryfibresonacuteindomethacininducedintestinalhyperpermeabilityintheelderlyarandomisedplacebocontrolledparallelclinicaltrial
AT robertjbrummer effectsofdietaryfibresonacuteindomethacininducedintestinalhyperpermeabilityintheelderlyarandomisedplacebocontrolledparallelclinicaltrial
AT idaschoultz effectsofdietaryfibresonacuteindomethacininducedintestinalhyperpermeabilityintheelderlyarandomisedplacebocontrolledparallelclinicaltrial
_version_ 1724761839120678912